AITP is an autoimmune disorder characterized by a low platelet
count and mucocutaneous bleeding1). Splenectomy is a major
treatment modality when more conservative medical therapy has failed. Despite an initial response rate of 7080%, 15% of patients will develop a recurrent thrombocytopenia. The presence of an accessory spleen should be sought in this case
Accessory spleens maybe found in a variety of locations, and may
not be readily apparent. Retained accessory splenic tissue can lead to recurrent ITP, which, this report (involving multiple relapses in a single patient) demonstrates.